Literature DB >> 28194077

Two Cases of NK/T Cell Lymphoma Presenting as Chronic Rhinosinusitis.

Rajat Thawani1,2, Shishir Seth1, Kuldeep Singh3, Jayanta Patowary1, Mano Bhadauria1, Pratap Kishore Das1.   

Abstract

T/NK cell lymphoma is a rare subtype of lymphoma that is known to be of aggressive nature. We present two cases of this disease that originally presented with symptoms consistent with chronic rhinosinusitis. We outline how we managed the diseases and review literature on it.

Entities:  

Keywords:  Chronic rhinosinusitis; NK cells; Non hodgkins lymphoma; Plastic surgery

Year:  2016        PMID： 28194077      PMCID： PMC5280861          DOI： 10.1007/s12288-016-0709-4

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


  7 in total

Review 1.  Natural killer cell cytotoxicity: how do they pull the trigger?

Authors:  Nicola J Topham; Eric W Hewitt
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

Review 2.  Natural killer-cell malignancies: diagnosis and treatment.

Authors:  Y-L Kwong
Journal:  Leukemia       Date:  2005-12       Impact factor: 11.528

Review 3.  NK/T cell lymphoma involving mediastinum: report of a case and review of literature.

Authors:  Xiang Li; Wei-Hua Liao; Jian-Hua Zhou; Bao-An Liu; Ji-Fang Wen; Zhong-Liang Hu
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 4.  The diagnosis and management of extranodal NK/T-cell lymphoma, nasal-type and aggressive NK-cell leukemia.

Authors:  Yok-Lam Kwong
Journal:  J Clin Exp Hematop       Date:  2011

5.  Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.

Authors:  Motoko Yamaguchi; Ritsuro Suzuki; Yok-Lam Kwong; Won Seog Kim; Yuichi Hasegawa; Koji Izutsu; Junji Suzumiya; Takayuki Okamura; Shigeo Nakamura; Keisei Kawa; Kazuo Oshimi
Journal:  Cancer Sci       Date:  2008-02-19       Impact factor: 6.716

Review 6.  Progress in understanding and managing natural killer-cell malignancies.

Authors:  Kazuo Oshimi
Journal:  Br J Haematol       Date:  2007-10-03       Impact factor: 6.998

7.  Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.

Authors:  Motoko Yamaguchi; Kensei Tobinai; Masahiko Oguchi; Naoki Ishizuka; Yukio Kobayashi; Yasushi Isobe; Kenichi Ishizawa; Nobuo Maseki; Kuniaki Itoh; Noriko Usui; Izumi Wasada; Tomohiro Kinoshita; Koichi Ohshima; Yoshihiro Matsuno; Takashi Terauchi; Shigeru Nawano; Satoshi Ishikura; Yoshikazu Kagami; Tomomitsu Hotta; Kazuo Oshimi
Journal:  J Clin Oncol       Date:  2009-10-05       Impact factor: 44.544
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.